MP-14.16: Sunitinib Therapy for Patients with Advanced Renal Cell Carcinoma (ARCC): Analysis for Safety and Activity on Single Institution Experience: Favourable Overall Survival According MSKCC-Group Risk
Title:
MP-14.16: Sunitinib Therapy for Patients with Advanced Renal Cell Carcinoma (ARCC): Analysis for Safety and Activity on Single Institution Experience: Favourable Overall Survival According MSKCC-Group Risk
Author:
Castellano, D. De la Rosa, F. Rodriguez Antolin, A. Villacampa, F. Sepulveda, J. Ghanem, I. Tejido, A. Rodriguez, A. Cortes-Funes, H. Leiva, O.